Welltower (NYSE:WELL – Get Free Report) had its target price increased by Wells Fargo & Company from $268.00 to $283.00 in a research note issued on Monday, Benzinga reports. The firm currently has an “overweight” rating on the real estate investment trust’s stock. Wells Fargo & Company‘s price target would indicate a potential upside of 14.57% from the stock’s previous close.
A number of other analysts also recently commented on WELL. Royal Bank Of Canada boosted their price objective on Welltower from $260.00 to $266.00 and gave the stock an “outperform” rating in a research note on Tuesday, November 10th. Evercore reaffirmed an “outperform” rating and set a $256.00 target price (down from $260.00) on shares of Welltower in a report on Monday, September 21st. BNP Paribas Exane lifted their target price on Welltower from $238.00 to $272.00 and gave the stock an “outperform” rating in a report on Tuesday, July 28th. Barclays dropped their price target on shares of Welltower from $259.00 to $246.00 and set an “equal weight” rating on the stock in a research report on Tuesday, October 13th. Finally, Jefferies Financial Group raised shares of Welltower to a “strong-buy” rating in a report on Friday, September 25th. One research analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $263.81.
Get Our Latest Stock Report on WELL
Welltower Stock Performance
WELL stock opened at $247.00 on Monday. The company has a 50-day simple moving average of $234.56 and a 200 day simple moving average of $221.17. The company has a market capitalization of $181.20 billion, a P/E ratio of 106.58, a PEG ratio of 1.16 and a beta of 0.79. The company has a quick ratio of 3.16, a current ratio of 3.16 and a debt-to-equity ratio of 0.39. Welltower has a fifty-two week low of $181.47 and a fifty-two week high of $255.20.
Welltower (NYSE:WELL – Get Free Report) last posted its quarterly earnings data on Monday, October 26th. The real estate investment trust reported $1.67 EPS for the quarter, beating analysts’ consensus estimates of $1.64 by $0.03. The business had revenue of $3.72 billion for the quarter, compared to analyst estimates of $3.64 billion. Welltower had a net margin of 12.08% and a return on equity of 3.61%. The business’s revenue for the quarter was up 38.4% on a year-over-year basis. During the same quarter last year, the business earned $1.34 earnings per share. Sell-side analysts predict that Welltower will post 6.50 earnings per share for the current fiscal year.
Insider Buying and Selling at Welltower
In related news, Director Andrew Gundlach acquired 5,000 shares of Welltower stock in a transaction dated Wednesday, August 26th. The stock was acquired at an average cost of $242.06 per share, with a total value of $1,210,300.00. Following the purchase, the director directly owned 30,000 shares in the company, valued at $7,261,800. The trade was a 20.00% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Purchased indirectly through two trusts. The transaction was executed in multiple trades at prices ranging from $241.59 to $242.59. The reported $242.06 price is the weighted-average purchase price. 0.37% of the stock is currently owned by corporate insiders.
Institutional Investors Weigh In On Welltower
A number of institutional investors and hedge funds have recently modified their holdings of the stock. Cetera Investment Advisers increased its stake in Welltower by 3.9% in the 3rd quarter. Cetera Investment Advisers now owns 236,702 shares of the real estate investment trust’s stock worth $54,498,000 after purchasing an additional 8,799 shares in the last quarter. Elequin Capital LP purchased a new stake in Welltower during the third quarter valued at about $62,000. Blue Chip Partners LLC boosted its stake in Welltower by 3.0% in the 3rd quarter. Blue Chip Partners LLC now owns 72,469 shares of the real estate investment trust’s stock worth $16,685,000 after purchasing an additional 2,132 shares during the period. Flputnam Investment Management Co. boosted its stake in Welltower by 5.9% in the 3rd quarter. Flputnam Investment Management Co. now owns 5,117 shares of the real estate investment trust’s stock worth $1,178,000 after purchasing an additional 285 shares during the period. Finally, L2 Asset Management LLC grew its position in Welltower by 6.8% during the 3rd quarter. L2 Asset Management LLC now owns 4,310 shares of the real estate investment trust’s stock worth $992,000 after purchasing an additional 273 shares in the last quarter. 94.80% of the stock is owned by institutional investors and hedge funds.
About Welltower
Welltower Inc. is a real estate investment trust focused on properties and services that support health care and aging. Its portfolio includes senior housing communities, outpatient medical facilities and post-acute care properties. The company works with senior housing operators, health care providers and other partners to own, lease and manage properties. Its operations span the United States, Canada and the United Kingdom. Founded in 1970 as Health Care REIT, the company adopted the Welltower name in 2015.
See Also
- Five stocks we like better than Welltower
- Meta’s Access to Capital Remains Strong, But Borrowing Is Becoming More Expensive
- 3 Large-Cap Stocks Are Outperforming the S&P 500 Without AI Hype
- Fossil Just Turned a Profit—Can Its Comeback Survive the Holidays?
- Beaming Up the Backlog: AeroVironment Lands $405M Laser Deal
Receive News & Ratings for Welltower Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Welltower and related companies with MarketBeat.com's FREE daily email newsletter.
